Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Shared Hospital Services (AMS) Gains from Sales and Divestitures (2020 - 2025)

American Shared Hospital Services' quarterly Gains from Sales and Divestitures came in at $163322.0 in Q4 2025, up 36.1% year-on-year from $120000.0 in Q4 2024, and up 36.1% quarter-over-quarter from $120000.0 in Q4 2024.

American Shared Hospital Services has reported Gains from Sales and Divestitures for 6 years, with the latest figure at $163322.0 in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures rose 36.1% year-over-year to $163322.0; the trailing twelve-month figure through Dec 2025 stood at $163322.0 (up 36.1% YoY), and the FY2025 full-year result was $163322.0, up 36.1% from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 stood at $163322.0, up from $120000.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $168000.0 in Q4 2021, with the low at $90000.0 in Q4 2023.
  • Average Gains from Sales and Divestitures over 5 years is $134664.4, with a median of $132000.0 recorded in 2022.
  • Year-over-year, Gains from Sales and Divestitures surged 86.67% in 2021 and sank 31.82% in 2023.
  • Tracing AMS's Gains from Sales and Divestitures over 5 years: stood at $168000.0 in 2021, then declined by 21.43% to $132000.0 in 2022, then sank by 31.82% to $90000.0 in 2023, then soared by 33.33% to $120000.0 in 2024, then jumped by 36.1% to $163322.0 in 2025.
  • The last three Gains from Sales and Divestitures figures came in at $163322.0 (Q4 2025), $120000.0 (Q4 2024), and $90000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 American Shared Hospital Services 9.66 Mn 13.07 Mn 906,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 163,322.00
Dec 31, 2025 163,322.00
Dec 31, 2024 120,000.00
Dec 31, 2024 120,000.00
Dec 31, 2023 90,000.00
Dec 31, 2023 90,000.00
Dec 31, 2022 132,000.00
Dec 31, 2022 132,000.00
Dec 31, 2021 168,000.00
Dec 31, 2021 168,000.00
Dec 31, 2020 90,000.00
Dec 31, 2020 90,000.00